NO166860C - Analogifremgangsmaate for fremstilling av terapeutisk aktive monosulfaktamer. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive monosulfaktamer.

Info

Publication number
NO166860C
NO166860C NO870031A NO870031A NO166860C NO 166860 C NO166860 C NO 166860C NO 870031 A NO870031 A NO 870031A NO 870031 A NO870031 A NO 870031A NO 166860 C NO166860 C NO 166860C
Authority
NO
Norway
Prior art keywords
sub
monosulfactures
preparation
therapeutically active
analogy procedure
Prior art date
Application number
NO870031A
Other languages
English (en)
Other versions
NO870031D0 (no
NO870031L (no
NO166860B (no
Inventor
Joseph Edward Sundeen
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NO870031D0 publication Critical patent/NO870031D0/no
Publication of NO870031L publication Critical patent/NO870031L/no
Priority to NO905385A priority Critical patent/NO905385D0/no
Publication of NO166860B publication Critical patent/NO166860B/no
Publication of NO166860C publication Critical patent/NO166860C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO870031A 1986-01-06 1987-01-05 Analogifremgangsmaate for fremstilling av terapeutisk aktive monosulfaktamer. NO166860C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO905385A NO905385D0 (no) 1986-01-06 1990-12-13 Tiazolderivater egnet som mellomprodukter ved fremstilling av terapeutisk aktive monosulfaktamer.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/816,475 US4684722A (en) 1986-01-06 1986-01-06 Monosulfactams

Publications (4)

Publication Number Publication Date
NO870031D0 NO870031D0 (no) 1987-01-05
NO870031L NO870031L (no) 1987-07-07
NO166860B NO166860B (no) 1991-06-03
NO166860C true NO166860C (no) 1991-09-11

Family

ID=25220721

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870031A NO166860C (no) 1986-01-06 1987-01-05 Analogifremgangsmaate for fremstilling av terapeutisk aktive monosulfaktamer.

Country Status (21)

Country Link
US (1) US4684722A (no)
EP (1) EP0229012B1 (no)
JP (1) JPS62158278A (no)
KR (1) KR900002244B1 (no)
AT (1) ATE64393T1 (no)
AU (3) AU602133B2 (no)
CA (1) CA1308107C (no)
DD (3) DD256700A5 (no)
DE (1) DE3770644D1 (no)
DK (1) DK3087A (no)
ES (1) ES2038127T3 (no)
FI (1) FI870030A (no)
GR (1) GR3002312T3 (no)
HU (2) HU198700B (no)
IL (1) IL81153A (no)
NO (1) NO166860C (no)
NZ (1) NZ218682A (no)
PH (1) PH23052A (no)
SU (1) SU1517762A3 (no)
YU (2) YU227886A (no)
ZA (1) ZA8771B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6452767A (en) * 1986-03-19 1989-02-28 Banyu Pharma Co Ltd 2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-vinyloxyimino)acetic acid derivative and production thereof
JPS6393796A (ja) * 1986-10-09 1988-04-25 Shin Etsu Chem Co Ltd ペプチド合成の脱保護基用薬剤
US5143913A (en) * 1988-04-04 1992-09-01 E. R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
JPH07165740A (ja) * 1994-11-07 1995-06-27 Banyu Pharmaceut Co Ltd ２−（２−アミノチアゾリル）−２−（１−カルボキシ−１−ビニルオキシイミノ）酢酸及びその製法
US5952306A (en) * 1996-01-16 1999-09-14 Merck & Co., Inc. Integrin receptor antagonists
CA2242877A1 (en) * 1996-01-16 1997-07-24 Merck & Co., Inc. Integrin receptor antagonists
US9120796B2 (en) 2013-10-02 2015-09-01 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
JP7184646B2 (ja) 2015-12-15 2022-12-06 メルク・シャープ・アンド・ドーム・エルエルシー ビアリールモノバクタム化合物および細菌感染治療のためのそれの使用方法
KR102408800B1 (ko) 2016-03-07 2022-06-13 머크 샤프 앤드 돔 코포레이션 비시클릭 아릴 모노박탐 화합물 및 박테리아 감염의 치료를 위한 그의 사용 방법
US10002721B1 (en) * 2017-02-27 2018-06-19 Carling Technologies, Inc. Multiple contact circuit breaker
MA50629A (fr) 2017-10-02 2021-03-31 Merck Sharp & Dohme Composés monobactames de chromane pour le traitement d'infections bactériennes
CN113754651B (zh) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU526540B2 (en) * 1976-04-12 1983-01-20 Fujisawa Pharmaceutical Co., Ltd. Oximes of substituted phenyl, thiazolyl - glyoxylic acids
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
GB1602725A (en) * 1977-04-27 1981-11-18 Glaxo Operations Ltd 7-(a-oxyiminoacetamido)-ceph-3-em-4-carboxylic acid derivatives
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US4533660A (en) * 1980-10-31 1985-08-06 E. R. Squibb & Sons, Inc. Antibacterial O-sulfated β-lactam hydroxamic acids
JPS58113174A (ja) * 1981-12-26 1983-07-05 Toyama Chem Co Ltd 新規なアゼチジン誘導体またはその塩類を含有する抗菌剤
US4443374A (en) * 1982-02-01 1984-04-17 E. R. Squibb & Sons, Inc. Process for preparing (3S)-3-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]-acetyl]amino]-2-oxo-1-azetidinesulfonic acid, and 4-substituted derivatives
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
JPS58206589A (ja) * 1982-05-26 1983-12-01 Yamanouchi Pharmaceut Co Ltd ２−アゼチジノン誘導体
JPS58210060A (ja) * 1982-05-31 1983-12-07 Takeda Chem Ind Ltd ２−オキソアゼチジン誘導体、その製造法および用途
HU189290B (en) * 1982-05-31 1986-06-30 Banyu Pharmaceutical Co Ltd,Jp Process for preparing new 2-oxo-1-azetidine-sulphonic acid derivatives and pharmaceutically acceptable salts thereof, further pharmaceutical compositions containing such derivatives as active substances
EP0096296B1 (de) * 1982-06-03 1987-07-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 1-Sulfo-2-oxoazetidinderivate
EP0096297B1 (de) * 1982-06-03 1988-06-15 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von 1-Sulfo-2-oxoazetidinderivaten
US4704457A (en) * 1982-06-21 1987-11-03 E. R. Squibb & Sons, Inc. Process for the preparation of (3S)-3-[[[2-(protected amino)-4-thiazolyl]-oxoacetyl]amino]-2-oxo-1-azetidinesulfonic acid and 4-substituted derivatives thereof
GB8413152D0 (en) * 1983-06-03 1984-06-27 Ici Pharma Cephalosporin derivatives
DE3342929A1 (de) * 1983-11-26 1985-06-05 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
ZA8771B (en) 1987-08-26
NO870031D0 (no) 1987-01-05
HUT48876A (en) 1989-07-28
HU198926B (en) 1989-12-28
KR900002244B1 (ko) 1990-04-07
AU617059B2 (en) 1991-11-14
DE3770644D1 (de) 1991-07-18
PH23052A (en) 1989-03-10
AU602133B2 (en) 1990-10-04
FI870030A (fi) 1987-07-07
HUT44540A (en) 1988-03-28
IL81153A0 (en) 1987-08-31
AU6680886A (en) 1987-07-09
KR870007164A (ko) 1987-08-17
EP0229012B1 (en) 1991-06-12
ES2038127T3 (es) 1993-07-16
DD267039A5 (de) 1989-04-19
DD267035A5 (de) 1989-04-19
NO870031L (no) 1987-07-07
DD256700A5 (de) 1988-05-18
HU198700B (en) 1989-11-28
IL81153A (en) 1991-06-10
DK3087A (da) 1987-07-07
FI870030A0 (fi) 1987-01-05
JPS62158278A (ja) 1987-07-14
NO166860B (no) 1991-06-03
EP0229012A1 (en) 1987-07-15
US4684722A (en) 1987-08-04
GR3002312T3 (en) 1992-12-30
AU5885190A (en) 1990-10-25
AU5885090A (en) 1990-11-15
NZ218682A (en) 1990-05-28
CA1308107C (en) 1992-09-29
YU127887A (en) 1988-04-30
SU1517762A3 (ru) 1989-10-23
DK3087D0 (da) 1987-01-05
YU227886A (en) 1988-02-29
ATE64393T1 (de) 1991-06-15

Similar Documents

Publication Publication Date Title
AU585988B2 (en) Nitrogen-containing heterocycles
GR880100248A (el) Ουσιες για την προφυλαξη και θεραπεια ρετροιογενην φλεγμωνων.
GB1534823A (en) Dental chairs or like patient supporting devices
IT8847884A0 (it) Elettrodo enzimatico e modulo di elettrodo nonche' relativo metodo di impiego
NO166860C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive monosulfaktamer.
FI875218A0 (fi) Ns. aktiivisesta panssarista tehty panssariseinä
NO173653C (no) Analogifremgangsmaate for fresmstilling av terapeutisk aktive 6-benzoksazinyl-og 6-benzotianzinyl-2,3,4,5-tetrahydropyridazin-3-oner
EP0350012A3 (en) Antiviral composition
NO168362C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive peptidforbindelser
JO1704B1 (en) New potent compounds
AU4059485A (en) Substituted benzopyrans
CA2053359A1 (en) Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
EG17752A (en) Benzoylurea derivatives
ES8701161A1 (es) Un procedimiento para preparar derivados de piridiloxi
CA1270247C (en) 3-ACYLAMINO-2-OXO-1-AZETIDINESULFONIC ACIDS
GR3007423T3 (no)
CA1271750C (en) 3-ACYLAMINO-2-OXO-1-AZETIDINESULFONIC ACIDS
FI841240A0 (fi) Foerbaettringar i makrolidantibiotika.
SU1203863A1 (ru) 6-циклогексил-2-окса-6-азаспиро (3,3) гептан, подавляющий рост сульфатвосстанавливающих бактерий
SE9000857D0 (sv) Novel use of theraeutically active compound
SU1116706A1 (ru) Производные 2,3,4,5-тетрагидро-1н-1,5-бензодиазепинона-2, проявляющие противовоспалительную активность
NO302577B1 (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive dekapeptider